Filing Details

Accession Number:
0001127430-17-000059
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-06-01 16:07:39
Reporting Period:
2017-05-30
Filing Date:
2017-06-01
Accepted Time:
2017-06-01 16:07:39
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1104506 Insmed Inc INSM Pharmaceutical Preparations (2834) 541972729
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1127430 A Christine Pellizzari 10 Finderne Avenue
Building 10
Bridgewater NJ 08807
General Counsel & Corp. Sec. No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2017-05-30 7,300 $15.23 27,300 No 4 P Direct
Common Stock Acquisiton 2017-05-31 2,700 $14.89 30,000 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct
Footnotes
  1. The price in column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $15.14 to $15.30, inclusive. The reporting person undertakes to provide to Insmed Incorporated, any security holder thereof, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote and footnote (2).
  2. The price in column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $14.83 to $14.96, inclusive.